Early Impact of the Inflation Reduction Act on Small Molecule vs Biologic Post-Approval Oncology Trials Read more about Early Impact of the Inflation Reduction Act on Small Molecule vs Biologic Post-Approval Oncology Trials
House Hearing Highlights NPC Research on IRA Impact on Orphan Drugs Read more about House Hearing Highlights NPC Research on IRA Impact on Orphan Drugs
NPC Submits Comments to CMS Regarding IPAY 2028 Draft Guidance Read more about NPC Submits Comments to CMS Regarding IPAY 2028 Draft Guidance
Early Signals of Inflation Reduction Act Impact on Pharmaceutical Investment Read more about Early Signals of Inflation Reduction Act Impact on Pharmaceutical Investment
Impacts of the Inflation Reduction Act on 2025 Formulary Coverage in Medicare Part D Plans Read more about Impacts of the Inflation Reduction Act on 2025 Formulary Coverage in Medicare Part D Plans
Evaluating Therapeutic Alternative Selection in Medicare's Initial Drug Price Negotiation Explanations Read more about Evaluating Therapeutic Alternative Selection in Medicare's Initial Drug Price Negotiation Explanations
The Inflation Reduction Act and Drug Development: Potential Early Signals of Impact on Post-Approval Clinical Trials Read more about The Inflation Reduction Act and Drug Development: Potential Early Signals of Impact on Post-Approval Clinical Trials
Observational Research Reveals Unintended Consequences of the Inflation Reduction Act on Post-Approval Clinical Trials Read more about Observational Research Reveals Unintended Consequences of the Inflation Reduction Act on Post-Approval Clinical Trials